Gastroenterology Department, Hospital Privado Universitario de Córdoba, Naciones Unidas 346, Córdoba CP 5016, Argentina; Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba, Argentina; Hospital Raúl Ferreyra, Córdoba, Argentina.
Clínica Universitaria Reina Fabiola, Córdoba, Argentina.
Dig Liver Dis. 2021 Jul;53(7):852-857. doi: 10.1016/j.dld.2021.01.006. Epub 2021 Jan 30.
Few studies have described the epidemiology and clinical behavior of inflammatory bowel disease (IBD) in South America. The aim of this study was to report on the prevalence, phenotype, and treatment of patients with IBD diagnosis in Capital Department of the Province of Córdoba, Argentina.
Data from adult patients (≥ 18 years-old) with IBD diagnosis that attended 12 public or private centers between 05/2014 and 05/2019 were included in a common registry.
A total of 655 patients were included (females: 53.4%). The ratio of ulcerative colitis (UC) (n = 561) to Crohn's disease (CD) (n = 88) was 6.38, with age-adjusted IBD prevalence being 70.1 (95% confidence interval 70.08-70.12) cases/100,000 habitants. Extraintestinal manifestations were diagnosed in 22.8% of patients, and left-side colitis (46%) was the most frequent extension in UC patients. In CD patients, colonic involvement (55.7%) and non-stricturing/non-penetrating behavior (74%) were the most frequent presentations. Biologic therapy was used in 36.4% of CD patients and 9.1% of UC patients (P<0.001).
In this population registry study, IBD prevalence was similar to that reported in other series in the region. A higher UC/CD ratio was observed due to the lower prevalence of CD compared to similar studies in South America.
南美洲鲜有研究描述炎症性肠病(IBD)的流行病学和临床行为。本研究旨在报告阿根廷科尔多瓦省首府炎症性肠病患者的患病率、表型和治疗情况。
本项基于共有登记处的数据纳入了于 2014 年 5 月至 2019 年 5 月间在 12 家公立或私立中心就诊的成年(≥18 岁)IBD 患者的数据。
共纳入 655 例患者(女性占 53.4%)。溃疡性结肠炎(UC)(n=561)与克罗恩病(CD)(n=88)的比例为 6.38,经年龄校正的 IBD 患病率为 70.1(95%置信区间 70.08-70.12)例/10 万人。22.8%的患者诊断出肠外表现,UC 患者中最常见的扩展类型为左侧结肠炎(46%)。CD 患者中,结肠受累(55.7%)和非狭窄/非穿透行为(74%)最常见。生物治疗在 CD 患者中的使用率为 36.4%,UC 患者中的使用率为 9.1%(P<0.001)。
在这项人群登记研究中,IBD 的患病率与该地区的其他系列研究相似。由于与南美洲的类似研究相比 CD 的患病率较低,因此观察到 UC/CD 比值较高。